Depression Often Seen in Patients Discharged From ICU

Share this content:
Depression Often Seen in Patients Discharged From ICU
Depression Often Seen in Patients Discharged From ICU

THURSDAY, Aug. 18, 2016 (HealthDay News) -- A significant number of former intensive care unit (ICU) patients experience depression, according to a review published in the September issue of Critical Care Medicine.

Dale Needham, M.D., professor of medicine at the Johns Hopkins University School of Medicine in Baltimore, and colleagues reviewed 42 studies that included 4,113 former ICU patients in the United States and United Kingdom.

Two to three months after being discharged from the ICU, 29 percent of patients had at least mild depression. Six months after discharge, rate of mild depression was 34 percent. One year after discharge, 29 percent of former ICU patients were mildly depressed. Moderate to severe depression was present in 17 percent of patients two to three months after discharge, and persisted six months after discharge. By 12 to 14 months, the rate of moderate to severe depression dropped slightly, to 13 percent. The risk of depression was highest among patients who had psychological symptoms before their ICU stay and among those who had psychological distress symptoms while in the ICU or hospital. These symptoms include anger, nervousness, and acute stress symptoms such as emotional detachment or flashbacks.

"If patients are talking about the ICU being stressful, or they're having unusual memories or feeling down in the dumps, we should take that seriously," Needham said in a university news release. "Health care providers, family members, and caregivers should pay attention to those symptoms and make sure they're not glossed over."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths